New oncology pharmacy at Charlotte Maxeke Johannesburg Academic Hospital

Cancer is one of the major causes of death in both the developed and undeveloped world, including South Africa. Adding to this, the rising incidence of cancer in South Africa means that more patients are in need of quality cancer care, which CMJAH can and does offer. The oncology pharmacy at CMJAH is incredibly important to the treatment of cancer patients.

"Patients, nurses and oncologists rely on the pharmacy and its pharmacists. The pharmacists do not just dispense cancer treatment - they are responsible for the rigorous safety and handling requirements for oncology medicines. This requires safe, clean and modern facilities, which we now have," said Professor Paul Ruff, head of Medical Oncology at CMJAH.

Prior to the upgrade, the hospital treated more than 25 000 patients a year and, thanks to the renovations, will now be able to improve on this number. It used to lack sufficient space and did not meet equipment requirements in order to guarantee safe, appropriate and cost effective use of the cancer medicines it was preparing.

The Innovative Cancer Care Foundation (ICCF), a non-profit organisation dedicated to addressing access issues for patients, did the refurbishment to the pharmacy. Thanks to a donation from leading oncology pharmaceutical company, Roche Products, the pharmacy can better manage its stock and now has the required safety equipment.

The CMJAH oncology pharmacy currently has six specialised pharmacists preparing cancer treatments. Although patients, family and friends never consistently interact with the pharmacists, they play an integral part of a patient's cancer care journey. If a patient or nurse has any questions about cancer medication, the oncology pharmacist is a helpful resource.

"The impact of the refurbished unit on staff and patients will be phenomenal. Staff morale will improve, as they are working in a pleasant and efficient environment and patients can receive their treatments safely and with dignity. It is a win-win for all," ICCF CEO, Jeanette Schwegman says.

"The company welcomed this opportunity to join ICFF and CMJAH in order to provide better care for cancer patients in the greater Gauteng area. We see this as a vital step in combatting the cancer burden faced by the South African public and we look forward to furthering this partnership with the Johannesburg Department of Health," said Dr Cindy Aitton, head of medical affairs at Roche Management Centre South Africa.